BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Apellis Pushing Forward in Macular Degeneration Despite Mixed Results

  Apellis Pharmaceuticals reported topline results from its Phase III DERBY and OAKS clinical trials for geographic atrophy secondary to age-related macular degeneration.

  September 10, 2021

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Clinical Catch-Up: September 6-10

  It was a very busy week for clinical trial announcements, although there were only three that were COVID-19-related. Here’s a look.

  September 10, 2021

   · 

  8 min read

   · 

  Mark Terry
• 

  Drug Development

  Cost, Confusion Proving Potentially Prohibitive in Aduhelm Rollout

  Biogen CEO Michel Vounatsos admitted Thursday that the company’s rollout of Aduhelm (aducanumab) for Alzheimer’s disease has been “slower than we anticipated.”

  September 10, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Business

  Selecta and Cyrus Partner on Therapeutic Proteins for Immune Disorders

  Selecta and Cyrus’ partnership will pair Selecta’s immune-modulating ImmTOR platform with Cyrus’ ability to redesign protein therapeutics through its de novo computational approach.

  September 10, 2021

   · 

  2 min read

   · 

  Heather McKenzie
• 

  Job Trends

  Be a Part of the Next Vaccine Breakthrough with Pfizer

  Philip Dormitzer explained that there are plenty of reasons to be excited about the prophylactic and therapeutic potential of mRNA.

  September 10, 2021

   · 

  6 min read

   · 

  Heather McKenzie
• 

  Business

  Biden Mandates COVID-19 Vaccination as “Patience Wears Thin”

  President Joe Biden took an aggressive step that mandates vaccination for 100 million Americans who are eligible for preventative medication.

  September 10, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Business

  Mammoth Biosciences Achieves Unicorn Status After Securing Over $195 Million

  Mammoth will use the funds to build and broaden its stable of next-generation CRISPR products to detect and cure various diseases.

  September 10, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Bio NC

  Previous SARS, Common Cold Infections Found to Heighten Vaccine Response

  A recently published study points to a previous SARS infection—plus vaccination—as the key to a robust immunity against SARS-CoV-2.

  September 10, 2021

   · 

  5 min read

   · 

  Heather McKenzie
• 

  Drug Development

  Bharat’s Intranasal Vaccine Speeds into Phase II on Heels of Strong Data

  This marks the second vaccine against the novel coronavirus developed by the India-based company and brings a significant milestone for intranasal formulations.

  September 10, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  FDA

  FDA Action Alert: Calliditas, Merck and BeiGene

  September is turning out to be a busy month for the U.S. Food and Drug Administration. Here’s a look at this week’s schedule for PDUFA dates.

  September 10, 2021

   · 

  4 min read

   · 

  Mark Terry